5-90694332-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032119.4(ADGRV1):​c.7576A>G​(p.Ile2526Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00366 in 1,613,950 control chromosomes in the GnomAD database, including 175 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I2526L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.020 ( 91 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 84 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.257

Publications

5 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015960932).
BP6
Variant 5-90694332-A-G is Benign according to our data. Variant chr5-90694332-A-G is described in ClinVar as Benign. ClinVar VariationId is 46376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0669 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032119.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
NM_032119.4
MANE Select
c.7576A>Gp.Ile2526Val
missense
Exon 33 of 90NP_115495.3
ADGRV1
NR_003149.2
n.7592A>G
non_coding_transcript_exon
Exon 33 of 90

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
ENST00000405460.9
TSL:1 MANE Select
c.7576A>Gp.Ile2526Val
missense
Exon 33 of 90ENSP00000384582.2
ADGRV1
ENST00000509621.1
TSL:1
n.273A>G
non_coding_transcript_exon
Exon 1 of 26
ADGRV1
ENST00000640403.1
TSL:5
c.4867A>Gp.Ile1623Val
missense
Exon 23 of 29ENSP00000492531.1

Frequencies

GnomAD3 genomes
AF:
0.0198
AC:
3008
AN:
152186
Hom.:
92
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0691
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00681
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00477
AC:
1188
AN:
249050
AF XY:
0.00377
show subpopulations
Gnomad AFR exome
AF:
0.0679
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000230
Gnomad OTH exome
AF:
0.00116
GnomAD4 exome
AF:
0.00198
AC:
2899
AN:
1461646
Hom.:
84
Cov.:
37
AF XY:
0.00172
AC XY:
1247
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.0665
AC:
2226
AN:
33472
American (AMR)
AF:
0.00349
AC:
156
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39698
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53402
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5766
European-Non Finnish (NFE)
AF:
0.000218
AC:
242
AN:
1111848
Other (OTH)
AF:
0.00416
AC:
251
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
198
396
593
791
989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0198
AC:
3013
AN:
152304
Hom.:
91
Cov.:
33
AF XY:
0.0188
AC XY:
1398
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0690
AC:
2868
AN:
41564
American (AMR)
AF:
0.00674
AC:
103
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68028
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
137
274
411
548
685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00659
Hom.:
45
Bravo
AF:
0.0220
ESP6500AA
AF:
0.0656
AC:
254
ESP6500EA
AF:
0.000241
AC:
2
ExAC
AF:
0.00573
AC:
693
EpiCase
AF:
0.000273
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Oct 16, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Nov 24, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 06, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.034
DANN
Benign
0.85
DEOGEN2
Benign
0.083
T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.26
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.42
N
REVEL
Benign
0.060
Sift
Benign
0.28
T
Sift4G
Benign
0.10
T
Polyphen
0.0020
B
Vest4
0.083
MVP
0.21
MPC
0.051
ClinPred
0.0031
T
GERP RS
-3.0
Varity_R
0.028
gMVP
0.49
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75191159; hg19: chr5-89990149; API